Your browser doesn't support javascript.
loading
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort.
Tariot, Pierre N; Lopera, Francisco; Langbaum, Jessica B; Thomas, Ronald G; Hendrix, Suzanne; Schneider, Lon S; Rios-Romenets, Silvia; Giraldo, Margarita; Acosta, Natalia; Tobon, Carlos; Ramos, Claudia; Espinosa, Alejandro; Cho, William; Ward, Michael; Clayton, David; Friesenhahn, Michael; Mackey, Howard; Honigberg, Lee; Sanabria Bohorquez, Sandra; Chen, Kewei; Walsh, Trisha; Langlois, Carolyn; Reiman, Eric M.
Afiliación
  • Tariot PN; Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Lopera F; Grupo de Neurociencias, Universidad de Antioquia, SIU, Medellín, Colombia.
  • Langbaum JB; Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Thomas RG; Department of Neurosciences, University of California San Diego School of Medicine, La Jolla, CA, USA.
  • Hendrix S; Pentara Corporation, Salt Lake City, UT, USA.
  • Schneider LS; USC State of California Alzheimer's Disease Research and Clinical Center, Keck Medicine of USC, Los Angeles, CA, USA.
  • Rios-Romenets S; Grupo de Neurociencias, Universidad de Antioquia, SIU, Medellín, Colombia.
  • Giraldo M; Grupo de Neurociencias, Universidad de Antioquia, SIU, Medellín, Colombia.
  • Acosta N; Grupo de Neurociencias, Universidad de Antioquia, SIU, Medellín, Colombia.
  • Tobon C; Grupo de Neurociencias, Universidad de Antioquia, SIU, Medellín, Colombia.
  • Ramos C; Grupo de Neurociencias, Universidad de Antioquia, SIU, Medellín, Colombia.
  • Espinosa A; Grupo de Neurociencias, Universidad de Antioquia, SIU, Medellín, Colombia.
  • Cho W; Genentech, a Member of the Roche Group, South San Francisco, CA, USA.
  • Ward M; Genentech, a Member of the Roche Group, South San Francisco, CA, USA.
  • Clayton D; Genentech, a Member of the Roche Group, South San Francisco, CA, USA.
  • Friesenhahn M; Genentech, a Member of the Roche Group, South San Francisco, CA, USA.
  • Mackey H; Genentech, a Member of the Roche Group, South San Francisco, CA, USA.
  • Honigberg L; Genentech, a Member of the Roche Group, South San Francisco, CA, USA.
  • Sanabria Bohorquez S; Genentech, a Member of the Roche Group, South San Francisco, CA, USA.
  • Chen K; Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Walsh T; Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Langlois C; Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Reiman EM; Banner Alzheimer's Institute, Phoenix, AZ, USA.
Alzheimers Dement (N Y) ; 4: 150-160, 2018.
Article en En | MEDLINE | ID: mdl-29955659
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Alzheimers Dement (N Y) Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Alzheimers Dement (N Y) Año: 2018 Tipo del documento: Article